Prediction of the list of products to be negotiated in 2019 national medical insurance catalogue

One week after the release of 2019 national health insurance catalog, the noise brought by various data analysis and comment articles gradually calmed down The biggest egg should be the list of 128 negotiated varieties that have not yet been made public Today, let's guess with you Our principle is "just guess, don't include right, guess wrong also don't compensate" First of all, list several official clues about the varieties to be negotiated: the state health insurance bureau will negotiate the drugs to be negotiated according to the relevant procedures determined by the expert review, and the agreed drugs will be included in the payment scope of the health insurance fund The specific list and relevant requirements will be issued separately On the basis of summing up the previous experience, this catalogue adjustment has further improved the method of negotiation access For the patent exclusive drugs with high clinical value but high price or great influence on the fund, 128 drugs are preliminarily determined to be included in the scope of access to the proposed negotiation, including 109 western drugs and 19 Chinese patent drugs through expert review and voting These drugs are mainly used to treat cancer, rare diseases and other major diseases, hepatitis C, hepatitis B, hypertension, diabetes and other chronic diseases Many products are new drugs approved by SFDA in recent years, including major innovative drugs in China As there are many varieties in this negotiation and it generally has a great impact on the fund, there is no requirement for the success rate in this negotiation Because the negotiated varieties are mainly for exclusive or patent period protected high-priced varieties, we first select the exclusive varieties (or dosage forms) that are not in the national medical insurance catalog in the past years from pharmago database of medicine magic cube, narrow the target range, and then infer the list of varieties to be negotiated based on the above clues As shown in the table below, a total of 106 Western medicines and 10 Chinese patent medicines are provided Source: medicine cube